APOE and Alzheimer disease: Immunotherapy against ApoE improves amyloid-associated phenotypes rather than Aβ (Xiong et al., 2021), suggesting elucidation of the regulatory mechanisms of APP expression can provide effective therapeutic strategies to interrupt the development or further progression of AD.